Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 1/2014

01.03.2014 | Review Article

Thyroid dysfunction in children with Down syndrome: a literature review

verfasst von: K. King, C. O’Gorman, S. Gallagher

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Introduction

This article is an evidence-based review of thyroid disease in children with Down syndrome, including a comparison between various professional guidelines for the management of thyroid disease in children with Down syndrome. Aspects of thyroid disease which are discussed include: congenital hypothyroidism; autoimmune thyroid disease; subclinical hypothyroidism; and hyperthyroidism. The national professional guidelines of Ireland, the United Kingdom, the United States of America, Australia and Canada are reviewed and compared.

Materials and methods

A literature search was conducted using Medline and PubMed. Search terms included ‘Down syndrome’ and ‘thyroid disease’, ‘hypothyroidism’, ‘hyperthyroidism’, ‘subclinical hypothyroidism’.

Results

Eighty-nine articles were retrieved and reviewed for inclusion. The guidelines on the medical management of children with Down syndrome of five expert groups have also been retrieved and reviewed for this discussion. These various guidelines offer largely similar advice regarding frequency of thyroid function tests, with only Ireland and the UK testing less frequently than annually. Only the United Kingdom and Irish Down Syndrome Medical Interest Group guidelines suggest testing for thyroid antibodies at every thyroid screen. None of the guidelines offer suggestions on the optimal course of action to pursue after the discovery of subclinical hypothyroidism.

Conclusion

In conclusion, more evidence is required regarding the optimal course of treatment for subclinical hypothyroidism. Such evidence may be best obtained by conducting a prospective randomized control trial.
Literatur
1.
Zurück zum Zitat Prasher VP (1999) Down syndrome and thyroid disorders—a review. Downs Syndr Res Pract 6(1):25–42PubMedCrossRef Prasher VP (1999) Down syndrome and thyroid disorders—a review. Downs Syndr Res Pract 6(1):25–42PubMedCrossRef
2.
Zurück zum Zitat Tuysuz B, Beker DB (2001) Thyroid dysfunction in children with Down’s syndrome. Acta Paediatr 90(12):1389–1393PubMedCrossRef Tuysuz B, Beker DB (2001) Thyroid dysfunction in children with Down’s syndrome. Acta Paediatr 90(12):1389–1393PubMedCrossRef
3.
Zurück zum Zitat Sharav T, Collins RM, Baab PJ (1988) Growth studies in infants and children with Down’s syndrome and elevated levels of thyrotropin. Am J Dis Child 142:1302–1306PubMed Sharav T, Collins RM, Baab PJ (1988) Growth studies in infants and children with Down’s syndrome and elevated levels of thyrotropin. Am J Dis Child 142:1302–1306PubMed
4.
Zurück zum Zitat Fort P, Lifshitz F, Bellisario R et al (1984) Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 104:545–549PubMedCrossRef Fort P, Lifshitz F, Bellisario R et al (1984) Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 104:545–549PubMedCrossRef
5.
Zurück zum Zitat Pascanu I, Banescu C, Benedek T et al (2009) Thyroid dysfunction in children with Down’s Syndrome. Acta Endocrinol (Bucharest, Rom.) 5(1):85–92CrossRef Pascanu I, Banescu C, Benedek T et al (2009) Thyroid dysfunction in children with Down’s Syndrome. Acta Endocrinol (Bucharest, Rom.) 5(1):85–92CrossRef
6.
Zurück zum Zitat Cutler AT, Benezra-Obeiter R, Brink SJ (1986) Thyroid function in young children with Down syndrome. Am J Dis Child 140:479–483PubMed Cutler AT, Benezra-Obeiter R, Brink SJ (1986) Thyroid function in young children with Down syndrome. Am J Dis Child 140:479–483PubMed
7.
Zurück zum Zitat Unachak K, Tanpaiboon P, Pongprot Y et al (2008) Thyroid functions in children with Down’s syndrome. J Med Assoc Thailand 91(1):56–61 Unachak K, Tanpaiboon P, Pongprot Y et al (2008) Thyroid functions in children with Down’s syndrome. J Med Assoc Thailand 91(1):56–61
8.
Zurück zum Zitat Van Trotsenburg ASP, Vulsma T, van Santen HM et al (2003) Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 88(4):1512–1515PubMedCrossRef Van Trotsenburg ASP, Vulsma T, van Santen HM et al (2003) Lower neonatal screening thyroxine concentrations in Down syndrome newborns. J Clin Endocrinol Metab 88(4):1512–1515PubMedCrossRef
9.
Zurück zum Zitat Van Trotsenburg AS, Vulsma T, Rozenburg-Marres SL (2005) The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 90(6):3304–3311PubMedCrossRef Van Trotsenburg AS, Vulsma T, Rozenburg-Marres SL (2005) The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. J Clin Endocrinol Metab 90(6):3304–3311PubMedCrossRef
10.
Zurück zum Zitat Karlsson B, Gustafsson J, Hedov G et al (1998) Thyroid dysfunction in Down’s syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 79(3):242–245PubMedCrossRef Karlsson B, Gustafsson J, Hedov G et al (1998) Thyroid dysfunction in Down’s syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 79(3):242–245PubMedCrossRef
11.
Zurück zum Zitat Loudon MM, Day RE, Duke EMC (1985) Thyroid dysfunction in Down’s syndrome. Arch Dis Child 60:1149–1151PubMedCrossRef Loudon MM, Day RE, Duke EMC (1985) Thyroid dysfunction in Down’s syndrome. Arch Dis Child 60:1149–1151PubMedCrossRef
12.
Zurück zum Zitat Ivarsson SA, Ericsson UB, Gustafsson J et al (1997) The impact of thyroid autoimmunity in children and adolescents with Down syndrome. Acta Paediatr 86(10):1065–1067PubMedCrossRef Ivarsson SA, Ericsson UB, Gustafsson J et al (1997) The impact of thyroid autoimmunity in children and adolescents with Down syndrome. Acta Paediatr 86(10):1065–1067PubMedCrossRef
13.
Zurück zum Zitat Rashid N, Mumtaz A, Mehmood S et al (2009) Assessment of thyroid dysfunction in Down syndrome patients. Pak Paediatr J 33(4):211–217 Rashid N, Mumtaz A, Mehmood S et al (2009) Assessment of thyroid dysfunction in Down syndrome patients. Pak Paediatr J 33(4):211–217
14.
Zurück zum Zitat Noble SE, Leyland K, Findlay CA et al (2000) School based screening for hypothyroidism in Down’s syndrome by dried blood spot TSH measurement. Arch Dis Child 82:27–31PubMedCrossRef Noble SE, Leyland K, Findlay CA et al (2000) School based screening for hypothyroidism in Down’s syndrome by dried blood spot TSH measurement. Arch Dis Child 82:27–31PubMedCrossRef
15.
Zurück zum Zitat Friedman D, Kastner T, Pond W et al (1989) Thyroid dysfunction in individuals with Down syndrome. Arch Intern Med 149:1990–1993PubMedCrossRef Friedman D, Kastner T, Pond W et al (1989) Thyroid dysfunction in individuals with Down syndrome. Arch Intern Med 149:1990–1993PubMedCrossRef
16.
17.
Zurück zum Zitat Caraccio N, Dardano A, Manfredonia F (2005) Longterm follow-up of 106 multiple sclerosis patients undergoing interferon-{beta} 1a or 1b therapy: predictive factors of thyroid disease development and duration. J Clin Endocrinol Metab 90(7):4133–4137PubMedCrossRef Caraccio N, Dardano A, Manfredonia F (2005) Longterm follow-up of 106 multiple sclerosis patients undergoing interferon-{beta} 1a or 1b therapy: predictive factors of thyroid disease development and duration. J Clin Endocrinol Metab 90(7):4133–4137PubMedCrossRef
18.
Zurück zum Zitat Gibson PA, Newton RW, Selby K et al (2005) Longitudinal study of thyroid function in Down’s syndrome in the first two decades. Arch Dis Child 90:574–578PubMedCrossRef Gibson PA, Newton RW, Selby K et al (2005) Longitudinal study of thyroid function in Down’s syndrome in the first two decades. Arch Dis Child 90:574–578PubMedCrossRef
19.
Zurück zum Zitat Rubello D, Pozzan GB, Casara D et al (1995) Natural Course of subclinical hypothyroidism in Down’s syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest 18:35–40PubMed Rubello D, Pozzan GB, Casara D et al (1995) Natural Course of subclinical hypothyroidism in Down’s syndrome: prospective study results and therapeutic considerations. J Endocrinol Invest 18:35–40PubMed
20.
Zurück zum Zitat Faria C, Ribeiro S, Kochi C et al (2011) TSH neurosecretory dysfunction (TSH-nd) in Down syndrome: low risk of progression to Hashimoto’s thyroiditis. Arq Bras Endocrinol Metabol. 55(8):628–631PubMedCrossRef Faria C, Ribeiro S, Kochi C et al (2011) TSH neurosecretory dysfunction (TSH-nd) in Down syndrome: low risk of progression to Hashimoto’s thyroiditis. Arq Bras Endocrinol Metabol. 55(8):628–631PubMedCrossRef
21.
Zurück zum Zitat Prasher V, Ninan S, Haque S (2011) Fifteen-year follow-up of thyroid status in adults with Down syndrome. J Intellect Disabil Res 55(4):392–396PubMedCrossRef Prasher V, Ninan S, Haque S (2011) Fifteen-year follow-up of thyroid status in adults with Down syndrome. J Intellect Disabil Res 55(4):392–396PubMedCrossRef
22.
Zurück zum Zitat Pueschel SM, Pezzullo JC (1985) Thyroid dysfunction in Down syndrome. Am J Dis Child 139:636–639PubMed Pueschel SM, Pezzullo JC (1985) Thyroid dysfunction in Down syndrome. Am J Dis Child 139:636–639PubMed
23.
Zurück zum Zitat Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux J et al (2009) Hyperthyroidism in a population with Down syndrome. Clin Endocrinol 71:110–114CrossRef Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux J et al (2009) Hyperthyroidism in a population with Down syndrome. Clin Endocrinol 71:110–114CrossRef
24.
Zurück zum Zitat Londhey VA, Rajadhyaksha GC, Barhate KS et al (2010) Hyperthyroidism in a case of Down Syndrome. J Assoc Physicians India 58:568–569PubMed Londhey VA, Rajadhyaksha GC, Barhate KS et al (2010) Hyperthyroidism in a case of Down Syndrome. J Assoc Physicians India 58:568–569PubMed
25.
Zurück zum Zitat Medical management of children and adolescents with Down syndrome in Ireland. (2001)Down’s Syndrome Medical Interest Group (DSMIG) UK § Ireland Medical management of children and adolescents with Down syndrome in Ireland. (2001)Down’s Syndrome Medical Interest Group (DSMIG) UK § Ireland
26.
Zurück zum Zitat Basic medical surveillance essentials for people with Down’s Syndrome-Thyroid Disorder. Down’s Syndrome Medical Interest Group (DSMIG) UK, 2001 Basic medical surveillance essentials for people with Down’s Syndrome-Thyroid Disorder. Down’s Syndrome Medical Interest Group (DSMIG) UK, 2001
27.
Zurück zum Zitat American Academy of Pediatrics (2011) Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 128:393–406CrossRef American Academy of Pediatrics (2011) Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 128:393–406CrossRef
28.
Zurück zum Zitat Tracy J (2011) Australians with Down syndrome-—Health matters. Aust Fam Physician 40(4):202–208PubMed Tracy J (2011) Australians with Down syndrome-—Health matters. Aust Fam Physician 40(4):202–208PubMed
29.
Zurück zum Zitat Van Cleve S, Cohen W (2006) Part I: Clinical practice guidelines with Down Syndrome from birth to 12 years. J Pediatr Health Care 20(1):47–54PubMedCrossRef Van Cleve S, Cohen W (2006) Part I: Clinical practice guidelines with Down Syndrome from birth to 12 years. J Pediatr Health Care 20(1):47–54PubMedCrossRef
30.
Zurück zum Zitat Van Cleve S, Cohen W (2006) Part II: Clinical practice guidelines for adolescents and young adults with Down syndrome: 12–21 years. J Pediatr Health Care 20(3):198–205PubMedCrossRef Van Cleve S, Cohen W (2006) Part II: Clinical practice guidelines for adolescents and young adults with Down syndrome: 12–21 years. J Pediatr Health Care 20(3):198–205PubMedCrossRef
Metadaten
Titel
Thyroid dysfunction in children with Down syndrome: a literature review
verfasst von
K. King
C. O’Gorman
S. Gallagher
Publikationsdatum
01.03.2014
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 1/2014
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-013-0994-y

Weitere Artikel der Ausgabe 1/2014

Irish Journal of Medical Science (1971 -) 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.